Stay updated on IMP321 with Paclitaxel in Metastatic Breast Carcinoma Clinical Trial
Sign up to get notified when there's something new on the IMP321 with Paclitaxel in Metastatic Breast Carcinoma Clinical Trial page.

Latest updates to the IMP321 with Paclitaxel in Metastatic Breast Carcinoma Clinical Trial page
- CheckyesterdayChange DetectedThe revision tag on the page was updated from v3.6.0 to v3.6.3, indicating a new release state of the study record. This reflects an internal update to the record history display rather than changes to the study content.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe record history shows recruitment is closed to new participants, and the history reflects a new revision tag (v3.6.0) while the previous revision tag (v3.5.5) was removed.SummaryDifference0.3%

- Check22 days agoChange DetectedA newer revision tag (v3.5.5) was added to the page history and the previous tag (v3.5.4) was removed. This reflects an updated page version in the study record history.SummaryDifference0.1%

- Check43 days agoChange DetectedRevision: v3.5.4 was added as the latest entry in the history, replacing Revision: v3.5.3. This documents an update to the record version rather than content changes to the study data.SummaryDifference0.1%

- Check65 days agoChange DetectedUpdates the page’s displayed software/version identifier from the previous revision to the current one.SummaryDifference0.1%

- Check72 days agoChange DetectedA new site revision v3.5.2 was added and the previous revision v3.5.0 was removed from the history.SummaryDifference0.1%

Stay in the know with updates to IMP321 with Paclitaxel in Metastatic Breast Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMP321 with Paclitaxel in Metastatic Breast Carcinoma Clinical Trial page.